Pearl 1: Amyloid in AD
LEARNING OBJECTIVES
Global Learning Objectives for AD Pearls Program:
Global Learning Objectives for AD Pearls Program:
- Describe the role of beta amyloid peptide in Alzheimer pathology.
- Describe the risk factors, prevalence, differential diagnostic considerations, and economic burdens of dementia.
- Discuss important family expectations and cultural determinants for effective dementia care.
- Describe common barriers experienced by primary care physicians in delivering effective dementia care
- Describe important outcomes and side effects associated with use of antidementia drugs in mild to moderate-stage AD
- List features that identify increased risk for motor vehicle crashes in people with dementia
Cost: $20.00 USD
Access Course
TARGET AUDIENCE
This program will provide state-of-the-art information and practical knowledge to those involved in care of patients with Alzheimer’s disease and related dementias, including:
- Primary care physicians, neurologists, psychiatrists and psychologists
- Nurse practitioners and physician assistants
- Registered Nurses and other members of nursing staff
- Long-term care facility senior staff, including medical directors, unit managers, and administrators
COURSE FACULTY
University of Virginia
- David S. Geldmacher, MD, FACP
Where are we with biomarker diagnosis and other tests for Alzheimer's Disease?
Watch Steven T. DeKosky, MD discuss testing issues in the following short video clips.
Copyright © 2011 by the Rector and Visitors of the University of Virginia
Office of Continuing Medical Education
P.O. Box 800711 Charlottesville, VA 22908
phone 434–924–5310 | fax 434–982–1415
Programming and Development by
